p53/MDM2 ( PDB )

This interaction is an anti-cancer target . MDM2 negatively regulates p53 , the "guardian of the genome," and is overexpressed in many human tumors. Inhibitors of p53/MDM2, some of which have progressed to clinical trials, target the MDM2 pocket defined by three anchor side chains of p53.